A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2006
12/27/2006	CN1883507A An effervescence tablet of cold-treating preparation and preparation method thereof
12/27/2006	CN1883506A A low-sugar granule for treating infants cold and preparation method thereof
12/27/2006	CN1883487A Powder placed inside shoes for treating foot odor and beriberi
12/27/2006	CN1883475A Compound teribinafine hydrochloride solution for animal
12/27/2006	CN1883474A A composition containing macrolide compound and porous water insoluble hydrophilic carrier
12/27/2006	CN1883471A A nano sodium cantharidin injection and preparation method thereof
12/27/2006	CN1883463A Use of ¿C(4-hydroxy-3-methoxyphenyl)-7-(4- hydroxyphenyl)-3,5-dihydroxy heptane
12/27/2006	CN1883459A Enteric coated preparation of entecavir and preparation method thereof
12/27/2006	CN1292073C Natural antitumor or antiviral substances and use of the same
12/27/2006	CN1292069C HIV-1 virus tat-protein mutants
12/27/2006	CN1291994C Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
12/27/2006	CN1291990C Biocidal compounds and their preparation
12/27/2006	CN1291984C 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry
12/27/2006	CN1291976C Antiretroviral pyridine and quinoline derivatives
12/27/2006	CN1291758C Coupling agent of CB and specific immune globulin IgG and medical use thereof
12/27/2006	CN1291755C Pharmaceutical compositions capable of enhancing the immunogenicity of poorly immunogenic antigens
12/27/2006	CN1291737C Chinese medicine composition for treating icterus hepatitis
12/27/2006	CN1291731C Chinese medicine for treating pulmonary fibrosis due to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
12/27/2006	CN1291730C Application of goldenrod in preparation of medicine for preventing and treating SARS virus
12/27/2006	CN1291729C Antiviral Chinese medicine preparation of Hypericum perforatumand its preparation process
12/26/2006	US7153967 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates
12/26/2006	US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives
12/26/2006	US7153936 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
12/26/2006	US7153880 Substituted diphenyl heterocycles useful for treating HCV infection
12/26/2006	US7153863 Therapeutic compounds based on pyrazolopyridline derivatives
12/26/2006	US7153855 Pyrazolopyridinyl pyrimidine therapeutic compounds
12/26/2006	US7153854 Pyrrolopyridazine derivatives
12/26/2006	US7153852 Skin disorders; antiinflammatory agents; brain disorders; chronic obstructive pulmonary disease; antiarthritic agents; inflammatory bowel disorders
12/26/2006	US7153851 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacterium
12/26/2006	US7153841 Conjugates with carriers; red shifted absorption; antiproliferative and antitumor agents; benign prostatic hyperplasia; diagnosis
12/26/2006	US7153838 Pharmacologically acceptable solvent vehicles
12/26/2006	US7153833 Therapeutic uses of SMR1 peptides
12/26/2006	US7153826 Cyclic peptide antibiotics including the loloatins are effective in the treatment of rosacea, particularly when administered in conjunction with an antibiotic such as metronidazole that is effective against anaerobic bacteria.
12/26/2006	US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
12/26/2006	US7153662 Inflammation-specific peptides and the uses thereof
12/26/2006	US7153526 Diagnosing bacteria infections; administering aqueou solution of silver colloids
12/26/2006	US7153524 administering polyethylene glycol or ethylene oxide-propylene oxide copolymers, with drugs, to improve delivery in the alimentary canal
12/26/2006	US7153511 Avian herpesvirus-based recombinant Infectious Bursal Disease vaccine
12/26/2006	US7153510 Recombinant vesiculoviruses and their uses
12/26/2006	US7153507 A human monoclonal antibody specifically binds to human IL-15 and to inhibit IL-15-induced proinflammatory effects; tumor necrosis factor; antiinflammatory, -arthritic, -carcinogenic, proliferative agents; rheumatic diseases; transplants
12/26/2006	US7153502 Food or drink product with a disinfection property of Helicobacter pylori
12/26/2006	US7153499 Promoting differentiation and maturation of immature dendritic cells in a regional lymph node (especially by administering a natural cytokine mixture parilymphatically) so that the cells deliver T-cell antigen to effect immunization
12/26/2006	US7153492 prophylactic or wound-healing treatment of lactating animals prone to develop or suffering from mastitis; chitosan, its derivatives and salts thereof and a second component capable of releasing CO2 in an acidic environment
12/21/2006	WO2006135763A2 Inhibitors of dna repair enzymes and methods of use thereof
12/21/2006	WO2006134877A1 Injection
12/21/2006	WO2006133708A1 Bioactive agents produced by submerged cultivation of a basidiomycete cell
12/21/2006	WO2006133654A1 USE OF NF-κB INHIBITOR FOR TREATING SEVERAL DISEASES
12/21/2006	WO2006133632A1 Nucleotide analogue prodrug and the preparation thereof
12/21/2006	WO2006133498A1 Acid addition salts of n-ethyi-n'-[2-methoxy-4-(5-methyi-4-{[(1s)-1-pyridin-3-ylbutyi]amino}pyrimidin- 2-yl)phenyl]urea and uses thereof
12/21/2006	WO2006133497A1 Combination treatment
12/21/2006	WO2006118605A3 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
12/21/2006	WO2006105194A3 Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
12/21/2006	WO2006095180A3 Humananized monoclonal antibodies against sars - associated coronavirus and treatment of patients with sars
12/21/2006	WO2006092599A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
12/21/2006	WO2006087548A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
12/21/2006	WO2006087544A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
12/21/2006	WO2006085141A3 Compositions and methods for treating or preventing hepadnaviridae infection
12/21/2006	WO2005121172A8 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
12/21/2006	WO2004069184A3 Methods for treating, preventing and detecting helicobacter infection
12/21/2006	US20060287510 Crystallization of IGF-1
12/21/2006	US20060287396 4-aryl quinols and analogs thereof as therapeutic agents
12/21/2006	US20060287374 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/21/2006	US20060287360 Novel compounds
12/21/2006	US20060287308 3-Aminoquinazolin-2,4-dione antibacterial agents
12/21/2006	US20060287281 Phosphohalohydrins, process for the production thereof and use thereof
12/21/2006	US20060287274 Phosphoepoxides, method for making same and uses
12/21/2006	US20060287268 Splice-region antisense composition and method
12/21/2006	US20060287235 Crystallization of IGF-1
12/21/2006	US20060287223 Remodeling and glycoconjugation of peptides
12/21/2006	US20060286128 Adjuvant combinations of liposomes and mycobacteriaial lipids for immunization compositions and vaccines
12/21/2006	US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis
12/21/2006	US20060286110 Bax-responsive genes for drug target identification in yeast and fungi
12/21/2006	US20060286069 G-CSF Conjugates
12/21/2006	US20060286068 Polypeptides exhibiting granulocyte colony-stimulating factor (G-CSF) activity; conjugates between the polypeptides and a non-polypeptide moiety (PEG); for treatment of neutropenia or leukopenia; low in vitro bioactivity, long in vivo half-life, reduced receptor-mediated clearance
12/21/2006	US20060286043 Delivery of antihistamines through an inhalation route
12/21/2006	US20060286042 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone
12/21/2006	DE102005027517A1 Verfahren zur Herstellung von Dihydrochinazolinen Process for the preparation of dihydroquinazolines
12/21/2006	CA2611917A1 Injection
12/21/2006	CA2611523A1 Stable fixed-dose unitary formulations comprising tenofovir, a surfatant and efavirenz
12/21/2006	CA2611023A1 Use of panton-valentine leukocidin for treating and preventing staphylococcus infections
12/21/2006	CA2597317A1 Uses of recombinant super-compound interferons
12/20/2006	EP1734050A2 Immunization of dairy cattle with GapC protein against streptococcus infection
12/20/2006	EP1733740A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
12/20/2006	EP1733735A2 Methods and products for inducing mucosal immunity
12/20/2006	EP1733726A1 Pharmaceutically active isoindoline derivatives
12/20/2006	EP1733725A1 Farmaceutical formulations comprising at least one HIV protease inhibiting compound
12/20/2006	EP1732907A1 Peptide deformylase inhibitors
12/20/2006	EP1732906A1 2-aminothiazole compounds useful as aspartyl protease inhibitors
12/20/2006	EP1732901A1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
12/20/2006	EP1732892A1 Tetrahydrocarbazoles and derivatives
12/20/2006	EP1732891A1 Resistance-repellent retroviral protease inhibitors
12/20/2006	EP1732604A2 Methods of treating hiv infection
12/20/2006	EP1732578A1 Plant-based medicament for the treatment of hepatitis c
12/20/2006	EP1732570A2 Novel hiv protease inhibitors
12/20/2006	EP1732569A1 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis
12/20/2006	EP1732547A2 Anti-hiv quinuclidine compounds
12/20/2006	EP1732525A1 Amorolfine patch for treating onychomycosis
12/20/2006	EP1519745B1 Method to enhance an immune response of nucleic acid vaccination
12/20/2006	EP1461308B1 Bacterial enzyme inhibitors
12/20/2006	EP1456171B1 Substituted cyclohexane derivatives

1 ... 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 ... 1798